Asset Details
Do you wish to reserve the book?
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality
Do you wish to request the book?
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality
2011
Overview
We retrospectively studied patients diagnosed with P. aeruginosa bloodstream infections (BSIs) in two Italian university hospitals. Risk factors for the isolation of multidrug-resistant (MDR) or non-MDR P. aeruginosa in blood cultures were identified by a case-case-control study, and a cohort study evaluated the clinical outcomes of such infections. We identified 106 patients with P. aeruginosa BSI over the 2-year study period; 40 cases with MDR P. aeruginosa and 66 cases with non-MDR P. aeruginosa were compared to 212 controls. Independent risk factors for the isolation of MDR P. aeruginosa were: presence of central venous catheter (CVC), previous antibiotic therapy, and corticosteroid therapy. Independent risk factors for non-MDR P. aeruginosa were: previous BSI, neutrophil count <500/mm3, urinary catheterization, and presence of CVC. The 21-day mortality rate of all patients was 33·9%. The variables independently associated with 21-day mortality were presentation with septic shock, infection due to MDR P. aeruginosa, and inadequate initial antimicrobial therapy.
Publisher
Cambridge University Press
Subject
/ Aged
/ Anti-Bacterial Agents - pharmacology
/ Anti-Bacterial Agents - therapeutic use
/ Biological and medical sciences
/ Blood
/ Catheter-Related Infections - drug therapy
/ Catheter-Related Infections - epidemiology
/ Catheter-Related Infections - microbiology
/ Cross Infection - drug therapy
/ Cross Infection - epidemiology
/ Cross Infection - microbiology
/ Drug Resistance, Multiple, Bacterial
/ Female
/ Fundamental and applied biological sciences. Psychology
/ HCAI and bloodstream infection
/ Hospitals, University - statistics & numerical data
/ Humans
/ Male
/ Patients
/ Pseudomonas aeruginosa - drug effects
/ Pseudomonas aeruginosa - isolation & purification
/ Pseudomonas Infections - drug therapy
/ Pseudomonas Infections - epidemiology
